JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coffin, V. L.
Right arrow Articles by Spealman, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coffin, V. L.
Right arrow Articles by Spealman, R. D.

Behavioral and cardiovascular effects of analogs of adenosine in cynomolgus monkeys

VL Coffin and RD Spealman

The behavioral and cardiovascular effects of six metabolically stable analogs of adenosine were studied in cynomolgus monkeys. Behavioral effects were determined in monkeys trained to respond under a 30- response fixed-ratio (FR) schedule of food presentation; cardiovascular effects were evaluated in a separate group of unanaesthetized monkeys seated at rest. Dose-effect curves for each drug were determined by administering cumulative doses i.v. during sequential components of the experimental session. All six analogs of adenosine produced dose- related decreases in FR responding with the following order of potency: 5'N-ethylcarboxamide adenosine (NECA) greater than 2-chloroadenosine (2- CA) greater than N6-R-phenylisopropyladenosine (R-PIA) greater than N6- cyclopentyladenosine (CPA) greater than N6-cyclohexyladenosine (CHA) greater than N6-S-phenylisopropyladenosine (S-PIA). In cardiovascular studies, all drugs except CPA produced dose-related decreases in mean blood pressure (MBP) with the following order of potency: NECA greater than 2-CA = R-PIA greater than CHA greater than S-PIA. CPA did not alter MBP at doses that decreased both FR responding and heart rate (HR). All drugs except NECA produced dose-related decreases in HR with the following order of potency: CPA greater than 2-CA greater than R- PIA greater than CHA greater than S-PIA. NECA increased HR at doses that decreased MPB and FR responding. Doses of caffeine that did not alter FR responding or cardiovascular function when given alone antagonized the behavioral effects of R-PIA, CHA, CPA and NECA. Caffeine also antagonized the effects of R-PIA, CHA and NECA on MBP and the effects of R-PIA and CPA on HR.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 241, Issue 1, pp. 76-83, 04/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
E. A. Van Schaick, R. A. A. Mathôt, J. M. Gubbens-Stibbe, M. W. E. Langemeijer, H. C. P. F. Roelen, A. P. Ijzerman, and M. Danhof
8-Alkylamino-Substituted Analogs of N6-Cyclopentyladenosine Are Partial Agonists for the Cardiovascular Adenosine A1 Receptors in Vivo
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 800 - 808.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1987 by the American Society for Pharmacology and Experimental Therapeutics.